Published: 2022-08-24

Lipid profile improving effect of Coriandrum sativum seed extract in rats

Zeinab M. Hassan, Afaf A. Afify, Faten I. Elsayed, AbuBakr M. El-Mahmoudy


Background: Hyperlipidaemia is a common disease in middle-aged and elderly people. It has received attention, as it indirectly affects the normal metabolism, blood viscosity and vital organ functions. It is a risk factor for cardiovascular and cerebrovascular diseases. Therefore, the aim of the present study was to evaluate the possible antihyperlipidemic effect of Coriander sativum seed extract (CSSE) in rats fed on high-fat diet.

Methods: A parallel study design was adopted on 42 albino rats, divided randomly into 7 groups with different treatments. After a 6 week-experimental course, blood samples were collected and analysed for lipid and organ function parameters. Phytochemical analysis was conducted on the used seed extract to detect the active principles underlying its effects.

Results: CSSE (150 and 300 mg/kg, orally, once daily) along with a high-fat (1.5% cholesterol+1.5% coconut oil, in diet) diet resulted in a significant (p≤0.05) improvement in plasma lipid parameters, including, total cholesterol, triacyglycerols and lipoproteins, compared to the high-fat group. group. The extract significantly (p≤0.05) improved hepatic (total proteins, albumin, globulins, total conjugated and unconjugated bilirubins, AST, ALT, GGT), cardiac (CK-MB and troponin-I) and renal (urea, creatinine & uric acid) biomarkers. Phytoanalysis of CSSE revealed presence of phlobatannin and flavonoids. The protection % produced by small and large doses of CSSE were dose-dependent and parallel to those of the standard antihyperlipidemic rosuvastatin (2 mg/dl orally, daily).

Conclusions: These data indicate that CSSE has a marked antihyperlipidemic effect and could be a source for a promising nutraceutical antihyperlipidemic drug depending on its high phenolic and flavonoid content.


Coriander sativum, Hyperlipidaemia, Phytoanalysis, Seed extract

Full Text:



Shattat GF. A review article on hyperlipidemia: types, treatments and new drug targets. Biomed Pharmacol J. 2015;7(1):399-409.

Onwe P, Folawiyo M, Anyigor-Ogah C, Umahi G, Okorocha A, Afoke A. Hyperlipidemia: etiology and possible control. IOSR J Dent Med Sci. 2015;14(10): 93-100.

Last AR, Ference JD, Falleroni J. Pharmacologic treatment of hyperlipidemia. Am Family Physician. 2011;84(5):551-8.

Ramkumar S, Raghunath A, Raghunath S. Statin therapy: review of safety and potential side effects. Acta Cardiol Sin. 2016;32(6):631.

Scaldaferri F, Pizzoferrato M, Ponziani FR, Gasbarrini G, Gasbarrini A. Use and indications of cholestyramine and bile acid sequestrants. Internal Emerg Med. 2013;8(3):205-10.

Guyton JR. Extended-release niacin for modifying the lipoprotein profile. Expert Opinion Pharmacother. 2004;5(6):1385-98.

Dhanapakiam P, Joseph JM, Ramaswamy V, Moorthi M, Kumar AS. The cholesterol lowering property of coriander seeds (Coriandrum sativum): mechanism of action. J Environ Biol. 2007;29(1):53.

Mandal S, Mandal M. Coriander (Coriandrum sativum L.) essential oil: Chemistry and biological activity. Asian Pacific J Tropic Biomed. 2015;5(6): 421-8.

Anilakumar K, Nagaraj N, Santhanam K. Effect of coriander seeds on hexachlorocyclohexane induced lipid peroxidation in rat liver. Nutr Res. 2001;21(11): 1455-62.

Parsaeyan N. The effect of coriander seed powder consumption on atherosclerotic and cardioprotective indices of type 2 diabetic patients. Nutr Res. 2012; 89(11):1523-8.

Farag SA. The efficiency of Coriander seeds as dietary additives in Broiler Chicken's diets. Egypt J Nutr Feed. 2013;16:491-501.

Sahib NG, Anwar F, Gilani AH, Hamid AA, Saari N, Alkharfy KM. Coriander (Coriandrum sativum L.): A potential source of high‐value components for functional foods and nutraceuticals‐A review. Phytother Res. 2013;27(10):1439-56.

Gaur N, Kukreja A, Yadav M, Tiwari A. Assessment of phytoremediation ability of Coriander sativum for soil and water co-contaminated with lead and arsenic: a small-scale study. Biotech. 2017;7(3):1-11.

Paget G, Barnes J. Toxicity tests. Evaluation of drug activities. Pharmacometrics. 1964;1:135-65.

Jung KT. Tietz Fundamentals of Clinical Chemistry, Carl A. Burtis, Edward R. In: Ashwood A, David EB, eds. St Louis, MO: Saunders/Elsevier; 2008:976.

Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973;19(5):476-82.

Tietz NW, Finley PR, Pruden E. Clinical guide to laboratory tests. Philadelphia: WB Saunders Company; 1995.

Warnick GR, Wood PD. National cholesterol education program recommendations for measurement of high-density lipoprotein cholesterol: Executive summary. The national cholesterol education program working group on lipoprotein measurement. Clin Chem. 1995;41(10):1427-33.

Bauer J. Clinical laboratory methods. 9th eds. St. Louis: The CV Mosby Co; 1982:494-5.

Hallbach J, Hoffmann GE, Guder WG. Overestimation of albumin in heparinized plasma. Clin Chem. 1991;37(4):566-8.

Silverman L, Christenson R, Grant G. Methods for the determination of proteins in serum and plasma. Textbook of clinical chemistry. Philadelphia: WB Saunders; 1986:579-90.

Martin N, Morris R. The albumin/globulin ratio: a technical study. J Clin Pathol. 1949;2(1):64.

Tietz NW, Fiereck EA. The spectrophotometric measurement of carboxyhemoglobin. Ann Clin Lab Sci. 1973;3(1):36-42.

Tietz N. Colorimetric method of serum aspartate and alanine aminotransferase. Fundament of clinical chemistry. Philadelphia: WB Saunders; 1970:447.

Heerspink W, Hafkenscheid J, Siepel H, van der Ven-Jongekryg J, Dijt C. Temperature-converting factors for enzymes: comparison of methods. Enzyme. 1980; 25:333-41.

Horder M, Elser R, Gerhardt W, Mathieu M, Sampson E. IFCC methods for the measurements of catalytic concentration of enzymes. J Int Feder Clin Chem. 1990;2(2):80-3.

Wu AH. Tietz clinical guide to laboratory tests-E-book. Netherlands: Elsevier Health Sciences; 2006.

Garcia-Segura S, Mostafa E, Baltruschat H. Electrogeneration of inorganic chloramines on boron-doped diamond anodes during electrochemical oxidation of ammonium chloride, urea and synthetic urine matrix. Water Res. 2019;160:107-17.

Morgan D, Dillon S, Payne R. The assessment of glomerular function: creatinine clearance or plasma creatinine?. Postgraduate Med J. 1978;54(631):302-10.

Tiffany T0, Jansen JM, Burtis CA. Enzymatic kinetic rate and end-point analyses of substrate, by use of aGEMSAECFast Analyzer. Clin Chem. 1972;18:829.

Phulsagar P, Kulkarni J, Velide L. Study of invitro Antioxidant, antibacterial activity and phytochemical analysis of Coriander Sativum. Think India J. 2019; 22(31):237-46.

Kumar RS, Balasubramanian P, Govindaraj P, Krishnaveni T. Preliminary studies on phytochemicals and antimicrobial activity of solvent extracts of Coriandrum sativum L. roots (Coriander). J Pharmacog Phytochem. 2014;2(6):45-9.

Mallik S, Sharangi A, Sarkar T. Phytochemicals of coriander, cumin, fenugreek, fennel and black cumin: a preliminary study. Nat Acad Sci Letters. 2020; 43(5):477-80.

Verma A, Dhanik J, Agarwal D, Arya N, Nand V. Qualitative phytochemical and cluster analysis of genotypic extracts of coriander leaves and seeds from Tarai and Kumaun regions of Uttarakhand, Himalayan state of India. IJCS. 2018;6(2):1566-71.

Nathenial S, Fatima A, Fatima R, Ijaz N, Saeed N, Shafqat A, et al. Phytochemical study of acetone solvent extract of Coriander sativum. J Pharmacog Phytochem. 2019;8(6):136-40.

Nirosha K, Divya M, Vamsi S, Sadiq M. A review on hyperlipidemia. Int J Novel Trends Pharm Sci. 2014; 4(5):81-92.

Onwe P, Folawiyo M, Okike P, Balogun M, Umahi G, Besong E, et al. Lipid profile and the growing concern on lipid related diseases. IOSJPBS. 2015; 10:2278-3008.

Janda E, Lascala A, Martino C, Ragusa S, Nucera S, Walker R, et al. Molecular mechanisms of lipid-and glucose-lowering activities of bergamot flavonoids. Pharm Nutr. 2016;4:S8-18.

Ramadan MF, Amer MMA, Awad AE-S. Coriander (Coriandrum sativum L.) seed oil improves plasma lipid profile in rats fed a diet containing cholesterol. Eur Food Res Technol. 2008;227(4):1173-82.

Chithra V, Leelamma S. Hypolipidemic effect of coriander seeds (Coriandrum sativum): mechanism of action. Plant Foods Human Nutr. 1997;51(2):167-72.

Chithra V, Leelamma S. Coriandrum sativum effect on lipid metabolism in 1, 2-dimethyl hydrazine induced colon cancer. J Ethnopharmacol. 2000; 71(3):457-63.

Ogedegbe HO, Brown DW. Lipids, lipoproteins, and apolipoproteins and their disease associations. Lab Med. 2001;32(7):384-9.

Asgarpanah J, Kazemivash N. Phytochemistry, pharmacology and medicinal properties of Coriandrum sativum L. Afr J Pharm Pharmacol. 2012; 6(31):2340-5.

Mohammed S, Saeed A, Al-Jubori O, Saeed A. Effect of daily supplement of coriander seeds powder on weight gain, rumen fermentation, digestion and some blood characteristics of Awassi ewes. J Res Ecol. 2018;6(2):1762-70.

Samoo HA, Maheshwari J, Babar AM, Sheikh AH, Khushk I, Bhutto MA, et al. Evaluation of the effects of plant aqueous extracts as anti-diabetic agents on alloxan induced diabetic male rabbits. Afr J Biotechnol. 2018;17(36):1111-8.

Zeng Y-Y, Zhang W-B, Cheng L, Wang L, Geng D-D, Tang W-J, et al. Cardiac parameters affect prognosis in patients with non-large atherosclerotic infarction. Molecul Med. 2021;27(1):1-10.

Patel DK, Desai SN, Gandhi HP, Devkar RV, Ramachandran A. Cardio protective effect of Coriandrum sativum L. on isoproterenol induced myocardial necrosis in rats. Food Chem Toxicol. 2012;50(9):3120-5.

Donia GR. Protective effect of Coriander (Corindrum sativum) against lead toxicity in rabbits. Eur J Biomed. 2019;6:520-32.